These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17121373)

  • 21. Two functions, one molecule: a metal-binding and a targeting moiety to combat Alzheimer's disease.
    Hureau C; Sasaki I; Gras E; Faller P
    Chembiochem; 2010 May; 11(7):950-3. PubMed ID: 20401891
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK; Verdile G; Bates KA; Martins RN
    Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
    Praticò D
    Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial biology in Alzheimer's disease pathogenesis.
    Galindo MF; Ikuta I; Zhu X; Casadesus G; Jordán J
    J Neurochem; 2010 Aug; 114(4):933-45. PubMed ID: 20492350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease.
    Zana M; Janka Z; Kálmán J
    Neurobiol Aging; 2007 May; 28(5):648-76. PubMed ID: 16624449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant approaches for the treatment of Alzheimer's disease.
    Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G
    Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons.
    Goldsbury C; Whiteman IT; Jeong EV; Lim YA
    Aging Cell; 2008 Oct; 7(5):771-5. PubMed ID: 18691184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
    Hasegawa T
    Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
    Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
    Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine and Alzheimer's disease: a modifiable risk?
    Dwyer BE; Raina AK; Perry G; Smith MA
    Free Radic Biol Med; 2004 Jun; 36(11):1471-5. PubMed ID: 15135184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress.
    Pensalfini A; Cecchi C; Zampagni M; Becatti M; Favilli F; Paoli P; Catarzi S; Bagnoli S; Nacmias B; Sorbi S; Liguri G
    Free Radic Biol Med; 2008 Apr; 44(8):1624-36. PubMed ID: 18294463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition.
    Steele M; Stuchbury G; Münch G
    Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.